[Registration Open] NCD Global Forum for Civil Society: Heart Disease, Stroke, and Other Cardiovascular Disease Session
date : 2/18/2019
Invitation to NCD Global Forum for Civil Society:
Heart Disease, Stroke, and Other Cardiovascular Disease Session
To confront the realities of non-communicable diseases (NCDs), HGPI is holding global forums within each therapeutic area, aiming to crystalize policy issues from patients’ perspectives, to propose necessary policies, and to bring together multi-stakeholders such as industry, academia, policy makers, and civil society including patient leaders from both inside and outside Japan to amass discussion on a level playing field. HGPI organized three forums on NCDs in 2018, focused on diabetes, dementia, and cancer and widely distributed the event reports in hopes of improving NCD policy measures in Japan as well as globally.
Given the momentum gathering around the “Basic Act on Cardiovascular Disease Measures” (English title tentative) which was established in December 2018, HGPI will hold a session that will focus on heart disease, stroke, and other cardiovascular disease. While crystalizing patient-centered policy issues that need to be reflected in the Cardiovascular Disease Measure Promotion Plans and advance discussions on the future of patient-centered healthcare delivery system for heart disease, stroke, and cardiovascular disease, the workshop will also aim to deepen understanding of the concerns that cut across NCDs.
We look forward to seeing you there.
■Date and Time
Tuesday, March 26, 2019 15:00-17:30
(Registration: 14:30, Reception: 17:30)
■Venue
International House of Japan
(5-11-16 Roppongi, Minato-ku, Tokyo)
■Organizer
Health and Global Policy Institute (HGPI)
■Participants
Patient Leaders, Health Policy Makers, Ministry Officials, Academia, Private Sector, etc.
(approx.80 persons)
■Program
(In no particular order/Honorifics and Titles omitted)
* Simultaneous English translation available throughout, speakers and details subject to change
14:30 Doors open
15:00-15:05 Welcoming Remark
Ryoji Noritake(CEO, HGPI)
15:05-15:25 Keynote Address
“Next Steps in the Development of Cardiovascular Disease Measure Promotion Plans”
Masahiro Sasaki (Director, Cancer and Disease Control Division, Health Service Bureau, MHLW (Ministry of Health, Labour and Welfare))
15:25-15:45 Roundtable Discussion
Creating A Patient-Centered Healthcare Delivery System for Cardiovascular Diseases
-Report from Patient Leader Workshops and Opinion Exchange
Hiroki Takeda (Executive Director, Japan Chronic Disease Self-Management Association (J-CDSMA))
-Roundtable Participants:
Midori Ishii (House of Councillors, The National Diet of Japan)
Mitsuaki Isobe (Sakakibara Heart Institute, President)
Hiroyuki Kawakatsu (Mitsui Sumitomo Aioi Life Insurance Company, Board Member of Japan Stroke Association)
Kazuo Minematsu (Chairman of Japan Stroke Association, Emeritus Director General of the National Cerebral and Cardiovascular Center)
Wil Woan (Heart Valve Voice, CEO)
Huimin Wang (Edwards Lifesciences, Corporate Vice President, Japan, Asia and Pacific)
Sarah Belson (World Stroke Association/ Stroke Association UK, International Development Manager)
Lisa Deck (Go Red for Women National Spokesperson, American Heart Association)
Moderator:
Shunichiro Kurita(Senior Associate, HGPI)
17:45- Reception
Top Research & Recommendations Posts
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Paper] “Rethinking Japan’s Health System Sustainability Under the Planetary Health Framework” Published in Health Systems & Reform (November 21, 2023)
- [Announcement] HGPI Joins Call for “Global Health and Medical Community Unite To Demand End Fossil Fuel Dependency at COP28” (November 1, 2023)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [Announcement] HGPI Endorsed “For the Health of People and Planet: Priorities for a Healthy COP28” (November 30, 2023)
- [Policy Recommendations] Furthering the Development of Precision Cancer Medicine —Proposals for Effective Policy Changes Based on Key Characteristics of Precision Medicine in Cancer Treatment— (September 20, 2022)
- [Activity Report] HGPI Submits Requests for the G7 Hiroshima Summit to the G7 Sous-Sherpa (December 23, 2022)
- [Urgent Recommendations] The Kidney Disease Control Promotion Project – Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration: Recommendations for Current Issues and Topics in Kidney Disease Control (May 11, 2022)
- [Policy Recommendations] Coming Together to Protect and Foster: Promoting Innovative and Sustainable Planetary Health in the Asia-Pacific Region to Build Resilient Health Systems (November 29, 2023)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
Featured Posts
-
2023-10-31
[Registration Open] Online Public Symposium “Dementia Risk Reduction: How Society Should Face the Individualization of Risk” (December 12, 2023)
-
2023-12-03
[Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
-
2023-12-04
[Registration Open] (Webinar) The 122nd HGPI Seminar: Keeping Pace with Growing Diversity of Health Information in Health Communication (December 19, 2023)
-
2023-12-05
[Policy Recommendations] Recommendation: Suggestions for Building a Resilient and Greener Health Care System Considering Sustainability and Environmental Concerns in the Revision of Medical, Nursing Care, and Disability Welfare Service Fees (December 6, 2023)
-
2023-12-05
[Registration Open] Online Global Expert Meeting: Considering Participation Among People Living with Dementia in the Formulation of National Dementia Strategies and in Policy Making Processes (January 22, 2024)